Markets › United States › NAS › ARQT

Arcutis Biotherapeutics Inc

NAS:ARQTHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$31.93+0.13%LiveIn session · ≈ AED 117.26 · Market cap $4.01B · Next earnings Tue 27 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	—	—	79.5%	91.6%	90.3%	90.2%	—	—
Operating margin	—	—	−8,183.0%	−404.5%	−65.3%	−3.3%	−3.3%	+0.0 pts
Net margin	—	—	−8,449.8%	−439.8%	−71.3%	−4.3%	−4.3%	+0.0 pts
EBITDA margin	—	—	−7,991.1%	−381.6%	−55.8%	0.7%	—	—
Return on equity	−50.1%	−69.3%	−148.6%	−295.6%	−88.9%	−8.5%	−8.5%	+0.0 pts
Return on assets	−45.5%	−50.6%	−69.3%	−76.8%	−40.1%	−3.7%	−3.7%	+0.0 pts
Return on capital employed	−49.6%	−55.1%	−73.3%	−81.8%	−47.9%	−4.0%	—	—
Debt / equity	0.0×	0.3×	1.0×	2.3×	0.7×	0.0×	0.0×	+0.0%
Debt / assets	1.7%	19.0%	45.1%	60.3%	31.7%	1.4%	—	—
Interest coverage	0.0×	0.0×	−19.3×	−8.1×	−4.7×	−1.0×	—	—
Current ratio	13.0×	12.1×	11.6×	7.1×	4.1×	3.2×	3.2×	+0.0%
Quick ratio	13.0×	12.1×	11.4×	6.8×	4.0×	3.0×	—	—
Cash ratio	2.9×	2.9×	1.4×	1.9×	0.9×	0.3×	0.3×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.2×	0.6×	0.9×	—	—
Inventory turnover	—	—	0.1×	0.4×	1.3×	1.6×	—	—
Receivables turnover	0.0×	0.0×	0.4×	2.3×	2.7×	2.6×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—